Update your location to show providers, locations, and services closest to you.
Anna Khanna, MD, an associate professor of neurology at the University of Florida College of Medicine and is a key member of the only comprehensive stroke program in north central Florida.
Dr. Khanna earned her B.A. in biological sciences from Rutgers University and her MD at Ross University School of Medicine. She completed her preliminary internal medicine residency year at the University of Medicine and Dentistry of New Jersey in 1999 and remained there to complete her neurology residency in 2002. Dr. Khanna became a stroke fellow there, and through its active vascular program, used both medical and endovascular therapies for the treatment of stroke. She completed her fellowship in 2003. She remained on faculty as an assistant professor, stroke program director and a mentor to medical students and residents. Dr. Khanna played an integral role in the community outreach for stroke education and traveled extensively to educate the public. As director of the outpatient stroke clinic and the resident clinic, Dr. Khanna introduced a comprehensive vascular ultrasound examination in the outpatient setting.
Dr. Khanna then joined the faculty at Saint Barnabas University Hospital in Livingston, NJ, where she was the stroke program director and mentored residents in internal medicine by introducing them to the multitude of vascular disorders. In both hospitals, she trained staff, provided continuing medical education and coordinated with the accreditors in their Joint Commission primary stroke center accreditation.
Dr. Khanna moved to Florida in 2007 and joined a private practice, providing general neurology care to the Marion County community. Dr. Khanna joined the faculty at UF as an assistant professor in the neurovascular division in 2011. She is currently providing care for stroke patients in inpatient and outpatient settings. She mentors two stroke fellows, medical students and residents. Dr. Khanna’s main interests are in acute stroke management and continuing research in several clinical trials treating acute stroke.
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is…
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
The SATURN trial aims to determine whether continuation vs. discontinuation of statin drugs after spontaneous lobar intracerebral hemorrhage (ICH) is the best strategy; and whether the decision to continue/discontinue statins should be influenced by…
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
February 16, 2023
To improve stroke outcomes for Floridians, UF Health is launching a statewide network of mobile stroke treatment units — specialized ambulances equipped to…
Department of Neurosurgery, +4 more
She waited. She wondered. She worried. Then, she listened carefully as he said her name. “Therese.” Four days after having a major stroke, Michael Markowitz…
